Urologix Inc ULGX
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.02
- Bid/Ask
- $0.00 / $0.01
- Shares Outstanding
- 21.82M
- Market Cap
- $21.82
- Volume/Avg
- 1,000 / 21,319
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Urologix Inc is a United States-based company engaged in the development, manufacturing, and marketing of minimally invasive medical products for the treatment of obstruction and symptoms due to Benign Prostatic Hyperplasia (BPH). The firm markets the Cooled ThermoTherapy (CTC) product line and the Prostiva Radio Frequency (RF) Therapy System (Prostiva). The CTC produces targeted microwave energy combined with a cooling mechanism to protect healthy tissue and enhance patient comfort. The Prostiva delivers radio frequency energy directly into the prostate destroying prostate tissue, reducing constriction of the urethra, and thereby relieving BPH voiding symptoms. The CTC product line includes the CoolWave and Targis Control Units and the CTC Advance catheter.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 61
- Website
- http://www.urologix.com
Valuation
|
Metric
|
ULGX
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
ULGX
|
|---|---|
Quick Ratio | 0.31 |
Current Ratio | 0.56 |
Interest Coverage | −5.12 |
Quick Ratio
No chart available
Profitability
|
Metric
|
ULGX
|
|---|---|
Return on Assets (Normalized) | −27.09% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
No chart available
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|grNfxf< | LOCK|yqbYP | $178B | |||
| Medtronic PLC
MDT
| LOCK|k<!<J%f | LOCK|gvLPT | $119B | |||
| Stryker Corp
SYK
| LOCK|$gg#&&J | LOCK|#Gl | $108B | |||
| Boston Scientific Corp
BSX
| LOCK|!R&!>< | LOCK|<M<k | $63B | |||
| Edwards Lifesciences Corp
EW
| LOCK|!LH>?@%! | LOCK|@BzVV | $49B | |||
| DexCom Inc
DXCM
| LOCK|$?q^ZftW | LOCK|Y^HY | $32B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|Fyqkg# | LOCK|%bg | $31B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|&!j | LOCK|>sf | $24B | |||
| Steris PLC
STE
| LOCK|>xD?%l | LOCK|@PP@ | $21B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|f>!S%g#> | LOCK|r!d | $18B |
United States